The institute
FEMTO's news

You are here

Launch of the European i-Nano-T project

The Bourgogne Franche-Comté region is banking on regional scientific and industrial synergy to drive innovation in nanomedicine.

The i-NanoT (Innovations in Theranostic Nanovectors) project, certified and funded under the Burgundy-Franche-Comté ERDF-ESF+ program for the period 2025-2028, is set to be officially launched on December 2, 2025, in Dijon on the campus of the University of Burgundy Europe. This large-scale project, with a total budget of €18.4 million (including €15.6 million in ERDF funding), represents a major initiative for the development of nanomedicine in the region.

Scientific context and challenges

Nanomedicine represents a decisive step forward for personalized medicine by exploiting the unique properties of nanometric structures to improve the diagnosis and treatment of diseases. Theranostic nanovectors, which are at the heart of the i-NanoT project, represent a major innovation by enabling the specific targeting of pathological cells, the controlled administration of active ingredients, and real-time monitoring of therapeutic efficacy. These approaches are particularly relevant to the challenges posed by cancers, inflammatory and infectious diseases, where precision treatment is crucial to maximize efficacy while minimizing side effects.

The consortium and strategic contributions

The consortium brings together the driving forces of academic research, with the participation of ICB, ICMUB, FEMTO-ST, Chrono-environnement, and UMR Right. Added to this are industrial partners committed to therapeutic innovation: VIVEXIA, Delpharm, and SON. The project also involves renowned healthcare institutions (CGFL, CTM Dijon Inserm) and technology transfer players (SAYENS and Santenov) to ensure an integrated approach from research to clinical application.

FEMTO-ST makes an essential contribution to the i-NanoT project by addressing one of the major challenges of drug nanovectorization: the structural and functional characterization of nanovectors. Through the Nano2BIO team in the MN2S department, the institute is mobilizing its expertise to explore the targeting and stealth properties of nanovectors by developing specific biointerfaces for targeted pathologies on biochips and sensors. FEMTO-ST deploys cutting-edge biophysical instrumentation and applies its expertise in surface and interface physicochemistry. These resources enable the qualification of biomolecular interactions and the investigation of structures at the nanometric scale. This approach positions the institute as a key player in optimizing the functional properties of these innovative systems.

Technological challenges and prospects

The project addresses several major scientific and technological obstacles, including the standardization of synthesis processes, the detailed characterization of the physicochemical properties of nanovectors, and the transition to industrial scale through the implementation of “kilo-lab” procedures. The aim is to develop a comprehensive platform dedicated to theranostic nanovectors, from design to preclinical validation, ensuring reproducibility and pharmaceutical quality.

Following this institutional launch, work will continue according to an ambitious schedule. The scale and collaborative nature of the project illustrate the regional momentum in favor of precision medicine. The expected benefits are significant, with a 30% increase in turnover for partner companies. The project thus reinforces the region's attractiveness in the field of nanotechnology/health, positioning the Bourgogne Franche Comté region as a center of excellence in the field of innovative biotherapies.

Lien : https://www.linkedin.com/company/i-nanot/ 

From left to right : C. ELIE-CAILLE, A. AL ASSAAD, W. BOIREAU, J. DEJEU, A. ROULEAU (FEMTO-ST Team)

  • Understanding the cytotoxicity of metallic nanoparticles

    A recent study published in the journal "Chemical Science" and involving FEMTO-ST gives new insights into the understanding of the mechanisms of DNA alteration in cells by metallic nanoparticles.

    Read more
  • Artificial intelligence for next-generation ultrafast photonics

    How can machine learning and associated methods improve the development of next-generation laser sources and revolutionize applications where ultrafast light plays a central role?

    Read more
  • Strong involvement of FEMTO-ST in the H2020 project "PhotonHub Europe"

    The objective of this project is to help European SMEs to increase their competitiveness through photonics with a online guidance, which will offer the support of 54 leading competence centers in Europe, including FEMTO-ST, which is also the scientific coordinator at the national level.

    Read more
  • First demonstration of self-confined nonlinear waves in plasmonic structures

    By providing the very first experimental evidence of the existence of this phenomenon, FEMTO-ST researchers and their partners hope to be able to generate this nonlinear effect using low intensity laser sources, in order to use it for nanophotonics applications.

    Read more
  • Mengjia Wang receives the « Chinese government award 2020 »

    As a PhD student of the Optics Department of FEMTO-ST , Mengjia Wang has been recognized by the Chinese Government for his outstanding work in the field of nanophotonics and plasmonics.

    Read more
  • Laurent LARGER named Fellow 2021 of OSA

    Full professor of Physics/Optics at the University of Franche-Comté and researcher at FEMTO-ST institute, Laurent Larger is rewarded for his pioneering work on nonlinear dynamics in optoelectronics and on the development of new architectures for photonic artificial intelligence.

    Read more
  • CNRS "Proof by Image" competition

     Discover the selection of the 20 images selected by the CNRS, one of which is presented by FEMTO-ST, and vote for the "audience award" photo.

    Read more
  • Imaging quantum interference of entangled photon pairs of extremely high dimensionality

    Researchers from the Optics Department have developed an imaging device allowing the spatial and temporal resolution of the phenomenon of quantum interference between pairs of entangled photons of extremely high dimensionality.

    Read more
  • Fei GAO Receives IEEE J.D. Irwin Early Career Award

    As a member of the SHARPAC team and Deputy Director of FEMTO-ST, Fei Gao has been recognized by the IEEE IES Society for his outstanding work in improving the reliability of hydrogen electric powertrains.

    Read more
  • Daniel HISSEL, winner of the CNRS 2020 Innovation Medal

    Full professor at the University of Franche-Comté, researcher at FEMTO-ST Institute and co-founder of a start-up on efficient hydrogen fuel cells, Daniel HISSEL is one of the four national winners of the CNRS 2020 Innovation Medal.

    Read more

Pages